BASF Opens New GMP Center in Michigan, US
BASF has opened a new Good Manufacturing Practice (GMP) Solution Center in Wyandotte, Michigan, to support the supply of bioprocessing ingredients and excipients for the biopharma and pharmaceutical industries.
The new facility expands BASF’s network of GMP sites, featuring advanced systems to support consistent, high-quality production. It includes clean room packaging, high-sensitivity analytical testing, and enhanced manufacturing capabilities for customized product development and precise process control.
Marion Kuhn, VP of Business Management, BASF Pharma Solutions commented, “Our new GMP Solution Center exemplifies BASF’s dedication to understanding and addressing the evolving needs of our customers in both the biopharma and pharmaceutical industries. This state-of-the-art facility will play a fundamental role in enabling us to collaborate closely with our customers worldwide on product development and GMP manufacturing in ways that are unique to the industry, further strengthening our position as an innovator in the pharmaceutical sector.”
“Wyandotte's new GMP Solution Center is a key example of BASF's commitment to innovative excellence,” said Benjamin Knudsen, VP of Research North America at BASF Corporation. “This expansion not only showcases our dedication to developing customized solutions, but it also highlights our ability to adapt and innovate in response to our customers’ needs. Together, we are paving the way for new innovative solutions.”
